Follow Us
Increased risk of myocardial infarction
Genetically-elevated lipoprotein(a) levels and increased risk of myocardial infarction
In a recent publication, Kamstrup and colleagues (JAMA 2009; 301:2331-2339) present study results consistent with a causal association between elevated lipoprotein(a) levels and increased risk of myocardial infarction.
Data from three studies of white individuals from Copenhagen, Denmark (CCHS, CIHDS and CIHDS) was used. In an editorial to this publication Thanassoulis and O'Donnell correspond that “this is an important biological finding that elevates the status of Lp(a)”.
For size independent measurement of lipoprotein(a)
(10-1106-01 Apo(a) ELISA)
Kit features:
nSpecific for human lipoprotein(a)
nMonoclonal antibodies for lot-to-lot consistency
nHigh precision
nEasy-to-use format
nAssay range: 0.3 – 5 U/l
nSample volume: 25μl
nSensitivity: 0.05 U/l
nIncubations: 60+60+15 min
nSamples: serum/plasma
n1x96 wells
Please read the article of Kamstrup and colleagues:
Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009). Genetically-elevated Lipoprotein (a) and increased risk of myocardial infarction. JAMA 301:2331-2339
Editorial:
Thanassoulis G and O'Donnell CJ (2009) Mendelian randomization. Nature's randomized trial in the post-genome era. JAMA 301:2386-2388
04/02/13 Proteomic approach identifies diabetes-associated proteins from rat plasma
03/18/13 Early metabolic defects in undernourished intrauterine growth restricted rats
03/04/13 Diabetic state can be efficiently reversed by insulin release from non-endocrine cells
03/03/13 Newsletter Issue 1, 2013
02/15/13 Zinc Transporter-8 does not have a substantial impact on mouse physiology
02/07/13 Words from our customer: Get accurate results, have more time for fun!